The study of xenobiotic-metabolizing enzymes and their role in toxicity in vivo using targeted gene disruption

被引:18
作者
Gonzalez, FJ [1 ]
机构
[1] NCI, NIH, Bethesda, MD 20892 USA
关键词
genetic polymorphism; cytochrome P450; gene knockout; transgenic mice; acetaminophen; caffeine;
D O I
10.1016/S0378-4274(98)00302-6
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Most of the chemicals that cause toxicity in animals are metabolized and this metabolism can either increase or decrease the extent of toxicity. A targe number of enzymes are involved in the metabolism of xenobiotics. Cytochromes P450 are among the most important and these enzymes are primarily involved in metabolic activation through oxidative metabolism. Transferases, including the glutathione S-transferases, N-acetyltransferases, UDP-glucuronosyltransferases, microsomal and cytosolic epoxide hydrolases, and NAD(P)H quinone oxidoreductase are also significant in xenobiotic metabolism and can play a role in chemical sensitivities. Polymorphisms in P450s and transferases have been found in experimental animals and humans in which a certain segment of the population, usually greater than 1%, are lacking expression of a particular enzyme. In humans, polymorphisms have been associated with adverse drug reactions but have not been shown to cause any serious developmental or physiological defects thus suggesting that in mammals, xenobiotic-metabolizing enzymes may only be required for metabolism of foreign chemicals and have no other critical role. To determine the roles of xenobiotic-metabolizing enzymes in mammalian development and physiological homeostasis, and in sensitivities to chemical toxicity and carcinogenesis, targeted gene disruption was carried out to produce gene knockout mice. Several lines of mice were produced and characterized and these are discussed. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 31 条
[1]   ACETAMINOPHEN HEPATOTOXICITY [J].
BLACK, M .
ANNUAL REVIEW OF MEDICINE, 1984, 35 :577-593
[2]  
BOYLAN JF, 1995, MOL CELL BIOL, V15, P843
[3]  
BURK RF, 1990, RES COMMUN CHEM PATH, V69, P115
[4]   Role of CYP1A2 in caffeine pharmacokinetics and metabolism: Studies using mice deficient in CYP1A2 [J].
Buters, JTM ;
Tang, BK ;
Pineau, T ;
Gelboin, HV ;
Kimura, S ;
Gonzalez, FJ .
PHARMACOGENETICS, 1996, 6 (04) :291-296
[5]   ROLE OF CYTOCHROME P4501A2 IN CHEMICAL CARCINOGENESIS - IMPLICATIONS FOR HUMAN VARIABILITY IN EXPRESSION AND ENZYME-ACTIVITY [J].
EATON, DL ;
GALLAGHER, EP ;
BAMMLER, TK ;
KUNZE, KL .
PHARMACOGENETICS, 1995, 5 (05) :259-274
[6]   Neonatal mouse assay for tumorigenicity: Alternative to the chronic rodent bioassay [J].
Flammang, TJ ;
VonTungeln, LS ;
Kadlubar, FF ;
Fu, PP .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1997, 26 (02) :230-240
[7]   CYTOCHROMES P450 EXPRESSION SYSTEMS [J].
GONZALEZ, FJ ;
KORZEKWA, KR .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1995, 35 :369-390
[8]   EVOLUTION OF THE P450-GENE SUPERFAMILY - ANIMAL PLANT WARFARE, MOLECULAR DRIVE AND HUMAN GENETIC-DIFFERENCES IN DRUG OXIDATION [J].
GONZALEZ, FJ ;
NEBERT, DW .
TRENDS IN GENETICS, 1990, 6 (06) :182-186
[9]   BIOTRANSFORMATION OF CAFFEINE, PARAXANTHINE, THEOBROMINE AND THEOPHYLLINE BY CDNA-EXPRESSED HUMAN CYP1A2 AND CYP2E1 [J].
GU, L ;
GONZALEZ, FJ ;
KALOW, W ;
TANG, BK .
PHARMACOGENETICS, 1992, 2 (02) :73-77
[10]   Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species [J].
Guengerich, FP .
CHEMICO-BIOLOGICAL INTERACTIONS, 1997, 106 (03) :161-182